U.S. Patent No. 10,888,283 B1

COVID patent Tech Patents

U.S. Patent No. 10,888,283 B1 (‘283), issued on January 12, 2021, to applicants/inventors Boonsieng Benjauthrit, Sorapod B. Benjauthrit, Vatcharee L. Benjauthrit, and Kamolchanok J. Benjauthrit, all of La Cañada, California.  The claims are directed to an apparatus called a COVID-19 Symptoms Alert Machine (CSAM) scanning device comprising the scanner, temperature scanner, a patient-provided health information …

Continue Reading

U.S. Patent No. 10,874,687 B1

COVID patent Tech Patents

U.S. Patent No. 10,874,687 B1 (‘687), issued on December 29, 2020, to inventors Jean-Pierre Sommadossi of Boston, Massachusetts, and Adel Moussa of Burlington, Massachusetts.  The applicant/assignee is Atea Pharmaceuticals, Inc. of Boston, Massachusetts, an anti-viral drug developer. The claims are directed to a method of therapeutic use for treating COVID-19, comprising the purine nucleotide phosphoramidate …

Continue Reading

U.S. Patent No. 10,780,052 B2

COVID patent Tech Patents

U.S. Patent No. 10,780,052 (‘052) B2, issued on September 22, 2020, to inventors Frank DeRosa, Michael Heartlein, and Shirang Karve of Cambridge, Massachusetts, and applicant/assignee, Translate Bio, Inc., of Lexington, Massachusetts.  The ‘052 patent claims priority to a provisional application filed October 22, 2013. The claims are directed to a method of therapeutic delivery of …

Continue Reading

U.S. Patent No. 10,752,636 B2

patent Tech Patents trademark

U.S. Patent No. 10,752,636 B2 (‘636) issued on August 25, 2020, entitled ”HIV Inhibitor Compounds.”  It was issued to inventors Elizabeth Bacon, Elbert Chin, Jeromy Cottell, Ashley Katana, Darryle Kato, John Link, Nathan Shapiro, Teresa Trejo Martin, and Zheng-Yu Yang.  The applicant/assignee is Gilead Sciences, Inc., of Foster City, California.  The ‘636 patent is a …

Continue Reading

U.S. Patent No. 10,695,361 B2

patent Tech Patents trademark

Given the current coronavirus pandemic, much has been discussed about possible vaccine trials and antiviral treatments to coronavirus.  One patent directed to therapeutic use is U.S. Patent No. 10,695,361 B2 (‘361) issued on June 30, 2020, entitled ”Methods for Treating Arenaviridae and Coronaviridae Virus Infections.”  It was issued to inventors Michael O’Neil Hanrahan Clarke, Joy …

Continue Reading

U.S. Patent No. D851,086 S – GDC Edition

design patent Tech Patents

The Game Developers Conference is open March 16 – 20, 2020, in San Francisco, California, the industry’s largest trade show.  Numerous exhibitors will be present, including Oculus.  A recently-issued patent is U.S. Patent No. D851,086 S, issued June 11, 2019, entitled “Wireless Game Controller.”  The inventors are Yi-yuan Chen and Peter Wesley Bristol of Seattle, …

Continue Reading